These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

664 related items for PubMed ID: 10491431

  • 21. Negative control of the HGF/c-MET pathway by TGF-β: a new look at the regulation of stemness in glioblastoma.
    Papa E, Weller M, Weiss T, Ventura E, Burghardt I, Szabó E.
    Cell Death Dis; 2017 Dec 13; 8(12):3210. PubMed ID: 29238047
    [Abstract] [Full Text] [Related]

  • 22. Scatter factor/hepatocyte growth factor (SF/HGF) content and function in human gliomas.
    Lamszus K, Laterra J, Westphal M, Rosen EM.
    Int J Dev Neurosci; 1999 Dec 13; 17(5-6):517-30. PubMed ID: 10571413
    [Abstract] [Full Text] [Related]

  • 23. Inhibition of intracerebral glioblastoma growth by local treatment with the scatter factor/hepatocyte growth factor-antagonist NK4.
    Brockmann MA, Papadimitriou A, Brandt M, Fillbrandt R, Westphal M, Lamszus K.
    Clin Cancer Res; 2003 Oct 01; 9(12):4578-85. PubMed ID: 14555533
    [Abstract] [Full Text] [Related]

  • 24. Hypoxia can induce c-Met expression in glioma cells and enhance SF/HGF-induced cell migration.
    Eckerich C, Zapf S, Fillbrandt R, Loges S, Westphal M, Lamszus K.
    Int J Cancer; 2007 Jul 15; 121(2):276-83. PubMed ID: 17372907
    [Abstract] [Full Text] [Related]

  • 25. Fully human monoclonal antibodies to hepatocyte growth factor with therapeutic potential against hepatocyte growth factor/c-Met-dependent human tumors.
    Burgess T, Coxon A, Meyer S, Sun J, Rex K, Tsuruda T, Chen Q, Ho SY, Li L, Kaufman S, McDorman K, Cattley RC, Sun J, Elliott G, Zhang K, Feng X, Jia XC, Green L, Radinsky R, Kendall R.
    Cancer Res; 2006 Feb 01; 66(3):1721-9. PubMed ID: 16452232
    [Abstract] [Full Text] [Related]

  • 26. Glioma inhibition by HGF/NK2, an antagonist of scatter factor/hepatocyte growth factor.
    Guerin C, Luddy C, Abounader R, Lal B, Laterra J.
    Biochem Biophys Res Commun; 2000 Jun 24; 273(1):287-93. PubMed ID: 10873600
    [Abstract] [Full Text] [Related]

  • 27. Scatter factor/hepatocyte growth factor in brain tumor growth and angiogenesis.
    Abounader R, Laterra J.
    Neuro Oncol; 2005 Oct 24; 7(4):436-51. PubMed ID: 16212809
    [Abstract] [Full Text] [Related]

  • 28. Constitutive c-Met signaling through a nonautocrine mechanism promotes metastasis in a transgenic transplantation model.
    Yu Y, Merlino G.
    Cancer Res; 2002 May 15; 62(10):2951-6. PubMed ID: 12019177
    [Abstract] [Full Text] [Related]

  • 29. Met and hepatocyte growth factor/scatter factor expression in human gliomas.
    Koochekpour S, Jeffers M, Rulong S, Taylor G, Klineberg E, Hudson EA, Resau JH, Vande Woude GF.
    Cancer Res; 1997 Dec 01; 57(23):5391-8. PubMed ID: 9393765
    [Abstract] [Full Text] [Related]

  • 30. Neuropilin-1 promotes human glioma progression through potentiating the activity of the HGF/SF autocrine pathway.
    Hu B, Guo P, Bar-Joseph I, Imanishi Y, Jarzynka MJ, Bogler O, Mikkelsen T, Hirose T, Nishikawa R, Cheng SY.
    Oncogene; 2007 Aug 16; 26(38):5577-86. PubMed ID: 17369861
    [Abstract] [Full Text] [Related]

  • 31. Expression of hepatocyte growth factor/scatter factor, its activator, inhibitors and the c-Met receptor in human cancer cells.
    Parr C, Jiang WG.
    Int J Oncol; 2001 Oct 16; 19(4):857-63. PubMed ID: 11562767
    [Abstract] [Full Text] [Related]

  • 32. Interactions between PTEN and the c-Met pathway in glioblastoma and implications for therapy.
    Li Y, Guessous F, DiPierro C, Zhang Y, Mudrick T, Fuller L, Johnson E, Marcinkiewicz L, Engelhardt M, Kefas B, Schiff D, Kim J, Abounader R.
    Mol Cancer Ther; 2009 Feb 16; 8(2):376-85. PubMed ID: 19190120
    [Abstract] [Full Text] [Related]

  • 33. Involvement of hepatocyte growth factor/scatter factor and met receptor signaling in hair follicle morphogenesis and cycling.
    Lindner G, Menrad A, Gherardi E, Merlino G, Welker P, Handjiski B, Roloff B, Paus R.
    FASEB J; 2000 Feb 16; 14(2):319-32. PubMed ID: 10657988
    [Abstract] [Full Text] [Related]

  • 34. Autocrine hepatocyte growth factor/scatter factor-Met signaling induces transformation and the invasive/metastastic phenotype in C127 cells.
    Jeffers M, Rong S, Anver M, Vande Woude GF.
    Oncogene; 1996 Aug 15; 13(4):853-6. PubMed ID: 8761307
    [Abstract] [Full Text] [Related]

  • 35. Reduced c-Met expression by an adenovirus expressing a c-Met ribozyme inhibits tumorigenic growth and lymph node metastases of PC3-LN4 prostate tumor cells in an orthotopic nude mouse model.
    Kim SJ, Johnson M, Koterba K, Herynk MH, Uehara H, Gallick GE.
    Clin Cancer Res; 2003 Nov 01; 9(14):5161-70. PubMed ID: 14613995
    [Abstract] [Full Text] [Related]

  • 36. Activation mechanisms of the urokinase-type plasminogen activator promoter by hepatocyte growth factor/scatter factor.
    Ried S, Jäger C, Jeffers M, Vande Woude GF, Graeff H, Schmitt M, Lengyel E.
    J Biol Chem; 1999 Jun 04; 274(23):16377-86. PubMed ID: 10347197
    [Abstract] [Full Text] [Related]

  • 37. Cyr61 mediates hepatocyte growth factor-dependent tumor cell growth, migration, and Akt activation.
    Goodwin CR, Lal B, Zhou X, Ho S, Xia S, Taeger A, Murray J, Laterra J.
    Cancer Res; 2010 Apr 01; 70(7):2932-41. PubMed ID: 20233866
    [Abstract] [Full Text] [Related]

  • 38. Hepatocyte growth factor/scatter factor induces feedback up-regulation of CD44v6 in melanoma cells through Egr-1.
    Recio JA, Merlino G.
    Cancer Res; 2003 Apr 01; 63(7):1576-82. PubMed ID: 12670907
    [Abstract] [Full Text] [Related]

  • 39. The expression of mRNAs for hepatocyte growth factor/scatter factor, its receptor c-met, and one of its activators tissue-type plasminogen activator show a systematic relationship in the developing and adult cerebral cortex and hippocampus.
    Thewke DP, Seeds NW.
    Brain Res; 1999 Mar 13; 821(2):356-67. PubMed ID: 10064822
    [Abstract] [Full Text] [Related]

  • 40. Insulin-like growth factor I is a comitogen for hepatocyte growth factor in a rat model of hepatocellular carcinoma.
    Price JA, Kovach SJ, Johnson T, Koniaris LG, Cahill PA, Sitzmann JV, McKillop IH.
    Hepatology; 2002 Nov 13; 36(5):1089-97. PubMed ID: 12395318
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 34.